Discover 3,580 paid clinical trials in Irvine, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trials in Irvine address a diverse range of conditions, from mental health disorders and neurological diseases to skin conditions and cardiovascular issues. As one of California’s thriving research hubs, the city provides participants with a chance to explore cutting-edge therapies and receive specialized care, all while contributing to the advancement of medical science in their region.
Filter
2
Filter results
Results: 3,580
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for
Endometrial Cancer
Location: Irvine CA, Orange CA, Solvang CA, Walnut Creek CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06952504
Phase3, Recruiting
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
for
Castration-Resistant Prostate Carcinoma,
Location: Irvine CA, Orange CA, Encinitas CA, La Jolla CA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06632977
Phase2, Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
for
Cutaneous Melanoma, Stage II
Location: Irvine CA, Orange CA, Los Angeles CA, Pasadena CA,
Sponsor: Melanoma and Skin Cancer Trials Limited
Sex: All
Age: 18+
Code: NCT03860883
Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Location: Irvine CA, Orange CA, Duarte CA, La Jolla CA,
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Sex: All
Age: 18+
Code: NCT04031677
Phase3, Recruiting
Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
for
Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia
Location: Irvine CA, Orange CA, Houston TX, Canton OH, Miami FL,
Sponsor: Hoth Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05639933
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Location: Irvine CA, Costa Mesa CA, Orange CA, Laguna Hills CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05633615
Phase2, Recruiting
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
for
Metastatic Urothelial Carcinoma,
Location: Irvine CA, Orange CA, Duarte CA, La Jolla CA, Dallas TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06439836
Phase1, Recruiting
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
for
Classic Follicular Lymphoma,
Location: Irvine CA, Orange CA, Yorba Linda CA, Long Beach CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06337318
Phase3, Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: Irvine CA, Orange CA, Los Angeles CA, Las Vegas NV,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase2, Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Irvine CA, Newport Beach CA, Costa Mesa CA, Orange CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04269902
Phase3, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Irvine CA, Orange CA, Torrance CA, Beverly Hills CA,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase3, Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
for
Metastatic Renal Cell Carcinoma,
Location: Irvine CA, Orange CA, Los Angeles CA, Beverly Hills CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05327686
Phase2, Recruiting
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
for
Advanced Hepatocellular Carcinoma,
Location: Irvine CA, Orange CA, Portland OR, Pittsburgh PA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06811116
Phase1, Phase2, Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Location: Irvine CA, Newport Beach CA, Orange CA, Upland CA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06661720
Phase3, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Irvine CA, Orange CA, Riverside CA, Los Angeles CA,